Ultibro ® Breezhaler ® reduced rate of all COPD exacerbations across different patient sub-groups vs Seretide ® in new analyses from FLAME study Analyses show that Ultibro Breezhaler lowered patients` ...
Boehringer Ingelheim's recently-approved Spiolto is more effective than GlaxoSmithKline's Seretide/Advair in improving lung function in patients with chronic obstructive pulmonary disease (COPD), ...
Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of asthma, surveyed physicians’ prescribing practices ...
If Novartis wants to be a respiratory giant in Europe, it’s going to have to weasel market share away from GlaxoSmithKline. Now it has some new data it’s hoping can help on that front. Sunday, the New ...
Washington, DC - December 11, 2008 - The following is GlaxoSmithKline's [NYSE: GSK] statement regarding recommendations of a combined Advisory Committee to the FDA on the use of asthma medicines ...
LONDON--(BUSINESS WIRE)--GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced a submission to the European Medicines Agency (EMA) for the extended use of once-daily ...
Asthma management guidelines advocate a stepwise approach to asthma therapy, including the addition of a long-acting bronchodilator to inhaled steroid therapy at step 3. This is almost exclusively ...
flutiform is the first pressurised metered-dose inhaler to combine the ICS, fluticasone propionate, with the fast-acting inhaled LABA, formoterol. 2 flutiform is licensed for asthma maintenance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback